Dr. Elijah Stommel | Toxicology | Best Researcher Award
Dr. Elijah W. Stommel is a distinguished neurologist born in Hamilton, Bermuda 🌊, currently serving as Professor of Neurology at the Geisel School of Medicine at Dartmouth 🧠, renowned for his clinical expertise, pioneering ALS research, and dedication to patient-centered care 💡; his prolific academic journey, consulting roles, and leadership in rare disease research reflect decades of unwavering service to neurology 🏥, academia 📚, and public health advocacy 🧬.
Profile
Education 🎓
Dr. Stommel holds an M.D. (1987) and a Ph.D. in Physiology (1984) from Boston University School of Medicine 🎓; he earned a B.A. with High Honors in Music from Bowdoin College 🎵 (1977), pursued advanced coursework at MIT 🏛️, and honed his research skills as a Research Assistant at the Marine Biological Laboratory in Woods Hole 🔬 — blending physiology, neurology, and music to form a truly interdisciplinary academic foundation 📘.
Experience 👨🏫
With over three decades in clinical neurology 🧠, Dr. Stommel progressed from Chief Resident at Dartmouth-Hitchcock (1990-91) to Professor of Neurology (2013–present) 👨🏫; he has served as Staff Neurologist at Dartmouth-Hitchcock Clinic since 1991 🏥, held multiple consultant roles across Vermont and New Hampshire 🗺️, and co-directs the Electromyography Lab ⚡, establishing himself as a trusted educator, clinician, and research mentor in both academic and hospital environments 🌟.
Awards & Recognitions 🏅
Dr. Stommel’s commitment to humanism and excellence in neurology earned him a nomination for the prestigious Tow Humanism in Medicine Award 🏆 (2011); he is a Fellow of the American Academy of Neurology 🎖️ and holds long-standing certifications in Electrodiagnostic Medicine and Neurology 🧠, complemented by leadership roles on numerous committees advancing research ethics, clinical trials, and medical education 📋💡.
Research Interests 🔬
Dr. Stommel’s research revolves around neurodegenerative diseases, especially ALS 🧬, exploring environmental toxins 🌿, nanotechnology 🧪, and biomarkers 🔍 to advance diagnostics and therapeutics; as an active reviewer and editor for journals like Nature Nanotechnology, Frontiers in Neurology, and Molecular Neurobiology 🧠, he continually shapes scientific discourse while his collaborative work with global ALS consortia helps identify novel causal pathways and treatment avenues 🌍💡.
-
Integrative co-registration of elemental imaging and histopathology for enhanced spatial multimodal analysis of tissue sections through TRACE
Y., Lu, Yunrui, S., Han, Serin, A., Srivastava, Aruesha, … S.P., Ho, Sunita Pullela, J.J., Levy, Joshua J.Bioinformatics Advances, 2025
-
Genome-Wide and Transcriptome-Wide Association Studies on Northern New England and Ohio Amyotrophic Lateral Sclerosis Cohorts
S., Li, Siting, J., Gui, Jiang, M.N., Passarelli, Michael N., … W.G., Bradley, Walter G., E.W., Stommel, Elijah W.Neurology: Genetics, 2024
-
Assessing Pulmonary Function in ALS using Electrical Impedance Tomography
-
Thoracic electrical impedance tomography for assessing progression of pulmonary dysfunction in ALS
S.B., Rutkove, Seward Brian, C.E., McIlduff, Courtney E., E.W., Stommel, Elijah W., … E.K., Murphy, Ethan K., R.J., Halter, Ryan J.Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2024